Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Sensors (Basel) ; 18(11)2018 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-30400674

RESUMEN

Meeting the ever-increasing global food, feed, and fiber demands while conserving the quantity and quality of limited agricultural water resources and maintaining the sustainability of irrigated agriculture requires optimizing irrigation management using advanced technologies such as soil moisture sensors. In this study, the performance of five different soil moisture sensors was evaluated for their accuracy in two irrigated cropping systems, one each in central and southwest Oklahoma, with variable levels of soil salinity and clay content. With factory calibrations, three of the sensors had sufficient accuracies at the site with lower levels of salinity and clay, while none of them performed satisfactorily at the site with higher levels of salinity and clay. The study also investigated the performance of different approaches (laboratory, sensor-based, and the Rosetta model) to determine soil moisture thresholds required for irrigation scheduling, i.e., field capacity (FC) and wilting point (WP). The estimated FC and WP by the Rosetta model were closest to the laboratory-measured data using undisturbed soil cores, regardless of the type and number of input parameters used in the Rosetta model. The sensor-based method of ranking the readings resulted in overestimation of FC and WP. Finally, soil moisture depletion, a critical parameter in effective irrigation scheduling, was calculated by combining sensor readings and FC estimates. Ranking-based FC resulted in overestimation of soil moisture depletion, even for accurate sensors at the site with lower levels of salinity and clay.

2.
Blood ; 125(9): 1418-26, 2015 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-25587036

RESUMEN

Hematopoietic and vascular development share many common features, including cell surface markers and sites of origin. Recent lineage-tracing studies have established that definitive hematopoietic stem and progenitor cells arise from vascular endothelial-cadherin(+) hemogenic endothelial cells of the aorta-gonad-mesonephros region, but the genetic programs underlying the specification of hemogenic endothelial cells remain poorly defined. Here, we discovered that Notch induction enhances hematopoietic potential and promotes the specification of hemogenic endothelium in differentiating cultures of mouse embryonic stem cells, and we identified Foxc2 as a highly upregulated transcript in the hemogenic endothelial population. Studies in zebrafish and mouse embryos revealed that Foxc2 and its orthologs are required for the proper development of definitive hematopoiesis and function downstream of Notch signaling in the hemogenic endothelium. These data establish a pathway linking Notch signaling to Foxc2 in hemogenic endothelial cells to promote definitive hematopoiesis.


Asunto(s)
Células Madre Embrionarias/citología , Endotelio Vascular/citología , Factores de Transcripción Forkhead/metabolismo , Regulación del Desarrollo de la Expresión Génica , Hematopoyesis/fisiología , Células Madre Hematopoyéticas/citología , Receptor Notch1/metabolismo , Animales , Apoptosis , Western Blotting , Diferenciación Celular , Linaje de la Célula , Proliferación Celular , Células Cultivadas , Células Madre Embrionarias/metabolismo , Endotelio Vascular/metabolismo , Factores de Transcripción Forkhead/genética , Células Madre Hematopoyéticas/metabolismo , Ratones , ARN Mensajero/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptor Notch1/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal , Pez Cebra/embriología , Pez Cebra/genética , Pez Cebra/metabolismo
3.
Nature ; 471(7339): 518-22, 2011 Mar 24.
Artículo en Inglés | MEDLINE | ID: mdl-21430780

RESUMEN

Melanoma is a tumour of transformed melanocytes, which are originally derived from the embryonic neural crest. It is unknown to what extent the programs that regulate neural crest development interact with mutations in the BRAF oncogene, which is the most commonly mutated gene in human melanoma. We have used zebrafish embryos to identify the initiating transcriptional events that occur on activation of human BRAF(V600E) (which encodes an amino acid substitution mutant of BRAF) in the neural crest lineage. Zebrafish embryos that are transgenic for mitfa:BRAF(V600E) and lack p53 (also known as tp53) have a gene signature that is enriched for markers of multipotent neural crest cells, and neural crest progenitors from these embryos fail to terminally differentiate. To determine whether these early transcriptional events are important for melanoma pathogenesis, we performed a chemical genetic screen to identify small-molecule suppressors of the neural crest lineage, which were then tested for their effects on melanoma. One class of compound, inhibitors of dihydroorotate dehydrogenase (DHODH), for example leflunomide, led to an almost complete abrogation of neural crest development in zebrafish and to a reduction in the self-renewal of mammalian neural crest stem cells. Leflunomide exerts these effects by inhibiting the transcriptional elongation of genes that are required for neural crest development and melanoma growth. When used alone or in combination with a specific inhibitor of the BRAF(V600E) oncogene, DHODH inhibition led to a marked decrease in melanoma growth both in vitro and in mouse xenograft studies. Taken together, these studies highlight developmental pathways in neural crest cells that have a direct bearing on melanoma formation.


Asunto(s)
Melanoma/genética , Melanoma/patología , Cresta Neural/enzimología , Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH/metabolismo , Transcripción Genética , Sustitución de Aminoácidos , Animales , Animales Modificados Genéticamente , Diferenciación Celular/efectos de los fármacos , Línea Celular Tumoral , Linaje de la Célula/efectos de los fármacos , Dihidroorotato Deshidrogenasa , Modelos Animales de Enfermedad , Regulación Neoplásica de la Expresión Génica , Genes p53/genética , Humanos , Isoxazoles/farmacología , Isoxazoles/uso terapéutico , Leflunamida , Melanoma/tratamiento farmacológico , Melanoma/enzimología , Ratones , Cresta Neural/efectos de los fármacos , Cresta Neural/metabolismo , Cresta Neural/patología , Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH/antagonistas & inhibidores , Proteínas Proto-Oncogénicas B-raf/antagonistas & inhibidores , Proteínas Proto-Oncogénicas B-raf/química , Proteínas Proto-Oncogénicas B-raf/genética , Proteínas Proto-Oncogénicas B-raf/metabolismo , Ratas , Células Madre/citología , Células Madre/efectos de los fármacos , Células Madre/patología , Transcripción Genética/efectos de los fármacos , Transcripción Genética/fisiología , Ensayos Antitumor por Modelo de Xenoinjerto , Pez Cebra/embriología , Pez Cebra/genética
4.
J Biol Chem ; 289(11): 7835-43, 2014 Mar 14.
Artículo en Inglés | MEDLINE | ID: mdl-24509859

RESUMEN

Mitochondrial iron is essential for the biosynthesis of heme and iron-sulfur ([Fe-S]) clusters in mammalian cells. In developing erythrocytes, iron is imported into the mitochondria by MFRN1 (mitoferrin-1, SLC25A37). Although loss of MFRN1 in zebrafish and mice leads to profound anemia, mutant animals showed no overt signs of porphyria, suggesting that mitochondrial iron deficiency does not result in an accumulation of protoporphyrins. Here, we developed a gene trap model to provide in vitro and in vivo evidence that iron regulatory protein-1 (IRP1) inhibits protoporphyrin accumulation. Mfrn1(+/gt);Irp1(-/-) erythroid cells exhibit a significant increase in protoporphyrin levels. IRP1 attenuates protoporphyrin biosynthesis by binding to the 5'-iron response element (IRE) of alas2 mRNA, inhibiting its translation. Ectopic expression of alas2 harboring a mutant IRE, preventing IRP1 binding, in Mfrn1(gt/gt) cells mimics Irp1 deficiency. Together, our data support a model whereby impaired mitochondrial [Fe-S] cluster biogenesis in Mfrn1(gt/gt) cells results in elevated IRP1 RNA-binding that attenuates ALAS2 mRNA translation and protoporphyrin accumulation.


Asunto(s)
5-Aminolevulinato Sintetasa/metabolismo , Regulación de la Expresión Génica , Proteína 1 Reguladora de Hierro/metabolismo , Proteínas de Transporte de Membrana/metabolismo , Porfirias/metabolismo , Animales , Blastocisto/citología , Diferenciación Celular , Línea Celular Tumoral , Femenino , Genotipo , Células HEK293 , Hemo/química , Humanos , Hierro/química , Proteínas Hierro-Azufre/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Biosíntesis de Proteínas , Protoporfirinas/metabolismo , Pez Cebra
5.
Nat Genet ; 42(12): 1113-7, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21057500

RESUMEN

The conversion of lineage-committed cells to induced pluripotent stem cells (iPSCs) by reprogramming is accompanied by a global remodeling of the epigenome, resulting in altered patterns of gene expression. Here we characterize the transcriptional reorganization of large intergenic non-coding RNAs (lincRNAs) that occurs upon derivation of human iPSCs and identify numerous lincRNAs whose expression is linked to pluripotency. Among these, we defined ten lincRNAs whose expression was elevated in iPSCs compared with embryonic stem cells, suggesting that their activation may promote the emergence of iPSCs. Supporting this, our results indicate that these lincRNAs are direct targets of key pluripotency transcription factors. Using loss-of-function and gain-of-function approaches, we found that one such lincRNA (lincRNA-RoR) modulates reprogramming, thus providing a first demonstration for critical functions of lincRNAs in the derivation of pluripotent stem cells.


Asunto(s)
Reprogramación Celular/genética , Células Madre Pluripotentes Inducidas/metabolismo , ARN no Traducido/metabolismo , Análisis por Conglomerados , Células Madre Embrionarias/metabolismo , Fibroblastos/metabolismo , Regulación de la Expresión Génica , Técnicas de Silenciamiento del Gen , Sitios Genéticos/genética , Humanos , Sistemas de Lectura Abierta/genética , ARN no Traducido/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Transcripción/metabolismo , Transcripción Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA